Dempsey Robert John's Form 4/A amendment
AmendedOKYO Pharma Ltd (OKYO) · filed Aug 7, 2026
- Accession no.
- 0001493152-26-036584
- Filed
- Aug 7, 2026, 4:15 PM ET
- Trade date
- Jul 22, 2026
- Filing delay
- 16 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jul 23, 2026
This filing lists 1 non-derivative transaction. Open-market purchases total $23.1K. It was filed 16 days after the trade.
This amendment replaces 0001493152-26-034409 (filed Jul 23, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dempsey Robert JohnCIK 0002125298 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2026 | COMMON STOCK | PPurchaseAcquired | +15,000 | $1.54 | +$23,085 | 15,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
This amendment has no footnotes.
Remarks
This Form 4/A amends the Form 4 filed on July 23, 2026 solely to correct the transaction code associated with this open market purchase. No other reported transactions are affected by this amendment.